Sermorelin for Women
What does research say about sermorelin for women? Review the evidence on skin, sleep, and weight, and learn when an evaluation may help.

Sermorelin stimulates the pituitary to release growth hormone. Research has not established that it reduces belly fat, improves sleep, or rejuvenates skin in women. A small 1997 study often cited for these claims used a related peptide. Persistent fatigue, sleep changes, and weight changes deserve an evaluation for more common causes.
How does sermorelin affect growth hormone as women age?
Sermorelin is a synthetic peptide modeled on part of the body’s growth hormone-releasing hormone. It signals a responsive pituitary to release growth hormone, which stimulates production of IGF-1. Growth hormone secretion generally changes with age, but age alone does not identify a deficiency or predict benefit from a prescription.

An older study found that 24-hour growth hormone secretion changes with age. That population-level finding cannot establish a fixed 15% decline every decade after age 30 for each woman. Growth hormone is released in pulses, including around slow-wave sleep, and levels vary with factors such as body composition and hormonal status. A low or borderline IGF-1 result requires clinical interpretation. [1–3]
What did the 1997 study find about skin, fat, and sleep?
A 1997 study enrolled 10 women and nine men ages 55 to 71. After four weeks of placebo, participants received a modified growth hormone-releasing peptide for 16 weeks. Skin thickness increased in both groups, while sleep quality and body weight showed no improvement. The study used a different peptide from sermorelin.

| Outcome | What researchers reported | What it means for women considering sermorelin |
|---|---|---|
| GH and IGF-1 | GH rose within about 10 minutes and the response lasted about two hours. IGF-1 rose within two weeks and moved back toward baseline by week 16. | The study measured hormone activity with a related peptide. It did not establish a timetable for feeling better. [4] |
| Skin thickness | Thickness increased in both women and men. | The study did not establish improved firmness, collagen-related appearance, stretch marks, hair, or nails. [4] |
| Fat, lean mass, and sleep | Weight and sleep quality did not improve. Lean body mass increased by about 1.26 kg in men only. Other body composition measures were unchanged. | No demonstrated loss of belly fat, increase in lean mass, or improvement in sleep for women. [4] |
The authors reported a temporary rise in blood lipids that resolved by the end of treatment. In a small subgroup of women on hormone therapy, fat mass increased, although there was no significant overall change by sex. The small sample and short follow-up cannot establish long-term safety. There is no validated four- to eight-week or three-month timeline for the advertised wellness outcomes with sermorelin. [2, 4]
When should women seek a clinical evaluation?
Persistent fatigue, changes in sleep, and changes in weight can have several causes. A clinician can review when symptoms began, menstrual changes, medication effects, and possible thyroid, iron, or sleep problems. Suspected growth hormone deficiency usually requires a more focused endocrine workup, particularly if there is a history of pituitary disease.
- Bring a short symptom history. Include changes in sleep, snoring, menstrual cycles, hot flashes, medications, and exercise tolerance. Depending on the history, your clinician may consider perimenopause, anemia, thyroid conditions, or a sleep disorder. [3, 5]
- Discuss injection questions with the pharmacist. Sermorelin has been studied as a subcutaneous injection. Injection-site reactions, headache, or flushing can occur. There is no established adult wellness schedule of five to seven injections per week for three to six months. If prescribed, confirm the exact formulation, concentration, storage, and administration instructions with the dispensing pharmacy. [2, 6]
Common questions about PEPLIX HEALTH
Peplix Health offers cash-pay telehealth through a model managed by Monarch Brands LLC. Independent, board-certified physicians evaluate symptoms, medical history, and any relevant labs before advising on care. A state-licensed pharmacy may fill a medically appropriate, eligible patient-specific prescription under Section 503A and applicable state rules when compounding is needed.
Is sermorelin FDA-approved for adult wellness?
Historical Geref had pediatric treatment and diagnostic uses. FDA has not approved sermorelin for adult anti-aging, fat loss, or sleep. Compounded products do not undergo FDA premarket review for safety, effectiveness, or quality. [2, 6, 7]
What can I ask about a 503A prescription?
Ask why the formulation is needed, which licensed pharmacy would dispense it, and what follow-up is planned. Qualified 503A compounding generally requires a valid prescription for an identified patient. The physician determines whether treatment is appropriate and individualizes the prescription when indicated. [7, 8]
For consultation information, see our longevity guide or start an online assessment.
Sources
- Zadik and colleagues. Age and 24-hour growth hormone secretion.
- Review. Growth hormone secretagogues and pharmacology.
- Endocrine Society. Adult growth hormone deficiency guideline.
- Khorram and colleagues. Study of a modified GHRH analog.
- International Menopause Society. Practitioner’s toolkit.
- FDA. Geref regulatory history.
- FDA. Compounding questions and answers.
- U.S. Code. Pharmacy compounding under Section 503A.


